Stent & Surgery 1.6

This comprehensive document addresses the complex issue of managing antiplatelet therapy in patients with coronary stents who are scheduled for surgery, highlighting a significant and evolving clinical challenge. The need for surgical intervention within the first year following coronary stenting has been estimated at approximately 4-8%, underscoring the importance of clear management strategies.

Developed collaboratively by cardiologists and surgeons, the consensus offers practical guidance on perioperative antiplatelet management tailored to patient-specific risk profiles. It includes stratification of ischemic risk based on clinical and procedural factors, alongside an assessment of hemorrhagic risk associated with various surgical procedures. These stratifications inform a consensus on optimal antiplatelet regimens, aiming to balance the risks of ischemia and bleeding effectively.

The associated application facilitates streamlined navigation through the document, allowing users to customize search parameters, view pertinent results, or share information via email, enhancing accessibility and usability for clinical decision-making.